
|Articles|August 18, 2009
Amarex Selects OmniComm to Provide eClinical Solutions
Advertisement
Mid-Atlantic based Contract Research Organization (CRO), to provide the company with eClinical solutions for an upcoming Phase III trial.
The trial will be investigating the use of a medical device for wound healing. The study will be conducted at over 30 sites and will recruit up to 300 patients over the course of two years.
Amarex also joins OmniComm’s CRO Preferred Program, which will allow them to offer OmniComm’s electronic data capture solution, TrialMaster, to their clients.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
A Shot in the Arm to Traditional Vaccine Trial Strategy
3
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
4
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
5




